Baxter International Inc. vs Merck & Company, Inc. — Stock Comparison

BAX
Baxter International Inc.
$17.21
▼ 2.10%
vs
MRK
Merck & Company, Inc.
$112.16
▲ 2.73%
Q·Score Winner
Merck & Company, Inc.
MRK6.7/10vs 4.8/10

Q·Score Breakdown

4.8
Bearish
Overall
6.7
Neutral
3.8
Quality
6.2
4.5
Health
7
4.7
Growth
6.2
7.1
Valuation
7.2
4
Sentiment
7.1
BAX

Consensus analyst target of $22.12 is 29% above current price.

currently unprofitable (-10% margin).

MRK

Forward P/E of 11.5× is low relative to sector peers.

Analyst Consensus

HOLD
Target $22.12 (+28.5%)
13 analysts
BUY
Target $129.74 (+15.7%)
27 analysts

Fundamentals

BAX
MRK
Trailing P/E
31.5×
8.5×
Forward P/E
11.5×
-9.7%
Profit Margin
13.6%
34.6%
Gross Margin
76.6%
ROE
2.9%
Revenue Growth
4.9%
Earnings Growth
0.62
Beta
0.28
Price / Book
$8.9B
Market Cap
$277.0B
$16 – $33
52-Week Range
$73 – $125

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →